Medpace Holdings Inc (MEDP) Stock Price, Quote & News

Company Profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 513 579 9911

Fax: 513 579 0444

Website: www.medpace.com

Address:

5375 Medpace Way, Cincinnati, United States

NVDAMillionaire May. 14 at 11:06 AM

$MEDP Great piece that accurately captures MEDP's current position. So if you want to refresh your understanding of MEDP or learn about MEDP for the first time, this is essential reading. https://everyticker.com/quote/MEDP/analysis/medpace-s-cancellation-crisis-meets-glp-1-gold-rush-a-high-stakes-test-of-cro-resilience-nasdaq-medp

0 · Reply

CapitalMonk May. 12 at 2:04 AM

$MEDP Price: $417.29 (-1.58%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.24% RSI: 25.8 | Momentum: Strong Downside Volume: -21.1% vs avg Volatility: 5.51% Support: $373.00 | Resistance: $530.97 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

ripster47 May. 6 at 12:54 PM

$MEDP Update Now breaking out into the gap fill Very Profitable Swing Trade since idea Idea working nicely so far Next Target 435s Top Position at @tenet_research See before after

0 · Reply

ripster47 May. 1 at 3:37 PM

$MEDP 🚨 This setup working nicely since the idea Now 1 HR MTF Flag for push into the gap on this swing name @Pharmdca @PharmDabbler @ripster47 See original trade idea in tweets below Profitable Biotech name https://x.com/TenetCharts

0 · Reply

BillionerOfKing May. 1 at 3:18 PM

$MEDP Current Stock Price: $417.36 Contracts to trade: $420.0 MEDP May 15 2026 Call Entry: $8.20 Exit: $10.78 ROI: 32% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ripster47 Apr. 30 at 9:20 PM

$XBI ❤️ Finally getting some love $XBI $CRVS $CTMX $TMDX $MEDP , 1 DAY of green after so much pain last few sessions Just need Yields to stay down and back up we go A Peace deal should help @Pharmdca @PharmDabbler @semodough @LTbioinvestor

0 · Reply

ripster47 Apr. 28 at 4:15 PM

$MEDP Low Float - Perfect Swing Long Setup! Watch the video to learn how to trade this repeatable pattern 🎯 https://x.com/i/status/2049142975859712332

0 · Reply

PenkeInvesting Apr. 25 at 5:47 AM

Fundamental analysis of $MEDP (Medpace Holdings, Inc.) based on financial data and reported results. #MEDP #Medpace

0 · Reply

maple_leaf1635377 Apr. 23 at 6:30 PM

$MEDP easy swing.

0 · Reply

WAJeff Apr. 23 at 5:48 PM

$MEDP $355 level? What are we thinking? I’d laugh if it happened but 14 day rsi at 20% is $309.40 and July 18, 2025 gap is right in the vicinity.

1 · Reply

MEDP Fraud Notice: Medpace Sued for Securities Fraud after 16% Stock Drop -- Investors Reminded to Contact BFA Law by June 8 Case Deadline

May 13, 2026, 6:18 AM EDT - 5 days ago

Medpace Lawsuit Reminder: Investors with Losses after Company Discloses Cancellation Rates are Urged to Contact BFA Law before June 8 Deadline - NASDAQ:MEDP

May 7, 2026, 6:13 AM EDT - 11 days ago

MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money

2026-04-24T12:40:41.000Z - 24 days ago

Medpace price target lowered to $400 from $460 at BMO Capital

2026-04-24T11:51:29.000Z - 24 days ago

Medpace price target lowered to $484 from $522 at RBC Capital

2026-04-24T10:36:05.000Z - 24 days ago

Medpace price target lowered to $477 from $565 at Baird

2026-04-24T09:35:33.000Z - 24 days ago

Medpace price target lowered to $450 from $500 at Barclays

2026-04-23T16:05:46.000Z - 25 days ago

Medpace falls -22.4%

2026-04-23T14:06:12.000Z - 25 days ago

Medpace falls -24.5%

Apr 23, 2026, 9:00 AM EDT - 25 days ago

Medpace Holdings Earnings Call Transcript: Q1 2026

Apr 22, 2026, 4:15 PM EDT - 25 days ago

Medpace Holdings, Inc. Reports First Quarter 2026 Results

Apr 1, 2026, 9:00 AM EDT - 6 weeks ago

Medpace Holdings, Inc. Investigated by the Portnoy Law Firm

Mar 24, 2026, 4:05 PM EDT - 7 weeks ago

Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026

2026-03-06T11:25:12.000Z - 2 months ago

Medpace upgraded to Equal Weight from Underweight at Barclays

2026-03-06T11:10:40.000Z - 2 months ago

Medpace upgraded to Equal Weight from Underweight at Barclays

2026-03-03T00:40:10.000Z - 2 months ago

Medpace initiated with an Outperform at RBC Capital

Feb 18, 2026, 9:00 AM EST - 3 months ago

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility

2026-02-18T10:55:16.000Z - 3 months ago

Medpace upgraded to Hold from Sell at TD Cowen

2026-02-13T11:39:22.000Z - 3 months ago

Medpace upgraded to Buy from Hold at Jefferies

2026-02-11T13:45:36.000Z - 3 months ago

Medpace price target lowered to $539 from $555 at Truist

2026-02-11T12:15:42.000Z - 3 months ago

Medpace price target lowered to $460 from $600 at BMO Capital

Feb 11, 2026, 2:00 AM EST - 3 months ago

Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial

2026-02-10T21:00:15.000Z - 3 months ago

Baird upgrades Medpace to Outperform on earnings selloff

2026-02-10T18:50:14.000Z - 3 months ago

Medpace upgraded to Outperform from Neutral at Baird

Feb 10, 2026, 9:00 AM EST - 3 months ago

Medpace Holdings Earnings Call Transcript: Q4 2025

Feb 9, 2026, 4:15 PM EST - 3 months ago

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

Jan 5, 2026, 4:05 PM EST - 4 months ago

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Oct 23, 2025, 11:15 AM EDT - 7 months ago

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back

Oct 23, 2025, 9:00 AM EDT - 7 months ago

Medpace Holdings Earnings Call Transcript: Q3 2025

Oct 22, 2025, 4:15 PM EDT - 7 months ago

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

Sep 23, 2025, 4:05 PM EDT - 8 months ago

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

Jul 22, 2025, 9:00 AM EDT - 10 months ago

Medpace Holdings Earnings Call Transcript: Q2 2025

Jul 22, 2025, 7:36 AM EDT - 10 months ago

This Clinical Trials Stock Just Soared 40%. What Caused It to Pop.

Jul 21, 2025, 4:15 PM EDT - 10 months ago

Medpace Holdings, Inc. Reports Second Quarter 2025 Results

Jun 23, 2025, 4:05 PM EDT - 11 months ago

Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Earnings Call Transcript: Q1 2025

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Medpace Holdings, Inc. Reports First Quarter 2025 Results

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

Feb 11, 2025, 9:00 AM EST - 1 year ago

Medpace Holdings Earnings Call Transcript: Q4 2024

Feb 10, 2025, 4:15 PM EST - 1 year ago

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results

Jan 2, 2025, 4:05 PM EST - 1 year ago

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025

NVDAMillionaire May. 14 at 11:06 AM

0 · Reply

CapitalMonk May. 12 at 2:04 AM

0 · Reply

ripster47 May. 6 at 12:54 PM

$MEDP Update Now breaking out into the gap fill Very Profitable Swing Trade since idea Idea working nicely so far Next Target 435s Top Position at @tenet_research See before after

0 · Reply

ripster47 May. 1 at 3:37 PM

0 · Reply

BillionerOfKing May. 1 at 3:18 PM

0 · Reply

ripster47 Apr. 30 at 9:20 PM

0 · Reply

ripster47 Apr. 28 at 4:15 PM

$MEDP Low Float - Perfect Swing Long Setup! Watch the video to learn how to trade this repeatable pattern 🎯 https://x.com/i/status/2049142975859712332

0 · Reply

PenkeInvesting Apr. 25 at 5:47 AM

Fundamental analysis of $MEDP (Medpace Holdings, Inc.) based on financial data and reported results. #MEDP #Medpace

0 · Reply

maple_leaf1635377 Apr. 23 at 6:30 PM

$MEDP easy swing.

0 · Reply

WAJeff Apr. 23 at 5:48 PM

$MEDP $355 level? What are we thinking? I’d laugh if it happened but 14 day rsi at 20% is $309.40 and July 18, 2025 gap is right in the vicinity.

1 · Reply

ripster47 Apr. 23 at 4:02 PM

$MEDP 💡 New Gap Fill Setup , 400 holds should get pushing higher back towards 500 Did same bounce after last earnings Medpace beat Q1. EPS $4.28 vs $3.86–$3.94 expected big beat. Revenue $706M vs $692–696M. Full-year guide raised to $2.78B–$2.89B, 8.9–12.8% growth. https://x.com/TenetCharts

0 · Reply

IjustTradeiT Apr. 23 at 2:43 PM

$MEDP 200 coming

1 · Reply

FlashMcGash Apr. 23 at 2:01 PM

$MEDP this is nuts! In under $400 ...hands over fists

0 · Reply

Jagomendy Apr. 23 at 1:42 PM

$MEDP cancellations an issue but have not impacted revenues to date. No expectation of any negative impact in 2026.

0 · Reply

Jagomendy Apr. 23 at 1:40 PM

$MEDP still hiring. 2026 Revenues and Income guidance intact. Steal at this level.

0 · Reply

Messerschmittbf109 Apr. 23 at 1:35 PM

$MEDP mmmmh

0 · Reply

Warren1989 Apr. 23 at 1:24 PM

$MEDP this conference call is a disaster. The medpace team needs to get their act together. They are not polished and fumbling for answers. I can see why this is crashing.

0 · Reply

OpenOutcrier Apr. 23 at 12:41 PM

$MEDP (-17.2% pre) Medpace Crashes: Here's What Overshadowed Its First-Quarter Sales, Earnings Beat https://ooc.bz/l/99783

0 · Reply

CatRocks Apr. 23 at 11:19 AM

$MEDP That $334 gap fill is looking a bit scary right now.

1 · Reply

Arcides Apr. 22 at 9:45 PM

$MEDP cutting feb low after hours, what a dump

0 · Reply

cubie Apr. 22 at 9:28 PM

$MEDP huh, how whales know to do deep itm poots, remember when $NFLX $UNH $MSFT had deep itm poots😅

1 · Reply

CatRocks Apr. 22 at 9:09 PM

$MCHP yay $TSM yay $NHI boo $MEDP boo $SPY

0 · Reply

Market Cap	11.86B
Revenue (ttm)	2.53B
Net Income (ttm)	451.12M
EPS (ttm)	N/A
PE Ratio	26.35
Forward PE	24.60
Profit Margin	17.83%
Debt to Equity Ratio	0.00

Volume	286,700
Avg Vol	395,600
Day's Range	N/A - N/A
Shares Out	28.56M
Stochastic %K	10%
Beta	1.19
Analysts	Sell
Price Target	$453.18